Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
Bioequivalence study to evaluate the pharmacokinetics of a new crizotinib encapsulated microsphere (eMS) formulation
Epistemonikos ID: 7be8ed3d74560a5166bcb91a2271c28af1d49e3a
First added on: Oct 02, 2023